Recent Advances in Diagnosis and Management of Urothelial Carcinoma

82.9K

views

127

authors

16

articles

Recent Advances in Diagnosis and Management of Urothelial Carcinoma

82.9K

views

127

authors

16

articles

Editorial

29 March 2021

Editorial: Recent Advances in Diagnosis and Management of Urothelial Carcinoma

Ja Hyeon Ku

and

Woonyoung Choi

1,960 views

0 citations

Editors

2

Ja Hyeon Ku

Department of Urology, College of Medicine, Seoul National University

Woonyoung Choi

The Johns Hopkins Hospital, Johns Hopkins Medicine

Impact

About

Bladder cancer is the fourth most common cancer in men in the United States (U.S.). The American Cancer Society estimates that 80,470 new cases of bladder cancer will be diagnosed in the U.S. in 2019 and that 17,670 people will die of the disease. Upper urinary tract urothelial carcinoma (UTUC) is a rare urologic malignancy, accounting for only 5% to 10% of all UCs; however, it shows an aggressive nature with high recurrence and progression rates. UC remains a common malignancy with few treatment advances in the last 20 years despite its high prevalence.

Nevertheless, there are many updates and ongoing trials on UC. In 2016–2017, five immune checkpoint inhibitors marked a new paradigm in the treatment of UC for patients with advanced or metastatic disease or who are unable to tolerate platinum-based chemotherapy. The successful use of immunotherapy in metastatic bladder cancer has led to an interest in using checkpoint immunotherapy in BCG-unresponsive patients as well as muscle-invasive bladder cancer as a peri-operative treatment. Moreover, ongoing research on robot-assisted radical cystectomy with urinary diversion and molecular subtype profiling of UC are actively progressing to get obvious evidence of the better outcome.

This article collection aims to report on, but is not limited to, the latest results of current and emerging diagnostic and therapeutic modalities used in the treatment of UC as well as basic science. Original Research and Review articles focused on the above-mentioned areas of UC (any subtype) are sincerely welcome.

Download ebook

PDF

EPUB

Share

Editors

Ja Hyeon Ku

Department of Urology, College of Medicine, Seoul National University

Woonyoung Choi

The Johns Hopkins Hospital, Johns Hopkins Medicine

Impact

82,900 Total views

58,907 Article views

22,274 Article downloads

1,719 Topic views

Published In

Frontiers in Oncology

Genitourinary Oncology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic